Method of blocking vascular leakage using an anti-ANG2 antibody
US9902767B2 · kind B2 · utility
2Cited by
11References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 29, 2014 |
| Grant date | Feb 27, 2018 |
| Priority date | — |
| Expiry date | Sep 17, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for the prevention and/or treatment of a disease accompanied by vascular leakage and/or vascular inflammation comprising administering an anti-Ang2 antibody or an antigen-binding fragment thereof that specifically binds to an angiogenesis-inducing factor Angiopoietin-2 (Ang2) and forms a complex with a Tie2 receptor and Ang2.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.